FR
ENG
CONTACT US
HOME
ABOUT LYSOGENE
PRESENTATION
TEAM
Karen AIACH
Olivier DANOS
Fanny VINCENT
Michaël HOCQUEMILLER
Alice LE MEUR
Vanessa FERREIRA
VISION AND COMMITMENTS
APPROACH
THE SAF-301 PROGRAM
P1-SAF-301 Clinical Trial
LYSOSOMAL STORAGE DISEASES
GENE THERAPY
PATIENT AREA
MISSION
Know us
People
Core values
Working with Patient Organizations
Code of conduct
OUR ACTIVITIES
Resources
Research
MPS awareness day 2013
NEWS
PRESS AREA
PARTNERSHIP
FURTHER DEVELOPMENT OF LYSOGENE’S GENE THERAPY PROGRAM
Â
Read more...
SAF-301 RECEIVED ORPHAN DRUG DESIGNATION IN THE UNITED STATES
Â
Read more...
NEW WEBSITE SECTION DEDICATED TO PATIENTS
Â
Read more...
IRDiRC press release
Read more...
9th ANNUAL SYMPOSIUM OF LSD NETWORK
Read more...
More Articles...
20th ESGCT Congress
19th ISOQOL Annual Conference
ORPHAN DRUGS & RARE DISEASES CONFERENCE
SSIEM 2012
«
Start
Prev
1
2
3
4
5
Next
End
»
Page 1 of 5
